| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | NPO | Common Stock | Options Exercise | $0 | +294 | +69% | $0.000000 | 721 | 15 Feb 2025 | Direct | F1 |
| transaction | NPO | Common Stock | Options Exercise | $0 | +217 | +30% | $0.000000 | 938 | 15 Feb 2025 | Direct | F1 |
| transaction | NPO | Common Stock | Tax liability | $27,979 | -145 | -15% | $192.96 | 793 | 15 Feb 2025 | Direct | |
| transaction | NPO | Common Stock | Options Exercise | $0 | +278 | +35% | $0.000000 | 1,071 | 16 Feb 2025 | Direct | F1 |
| transaction | NPO | Common Stock | Tax liability | $14,279 | -74 | -6.9% | $192.96 | 997 | 16 Feb 2025 | Direct | |
| holding | NPO | Common Stock | 6,428 | 15 Feb 2025 | By IRA |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | NPO | Restricted Stock Units | Options Exercise | $0 | -294 | -100% | $0.000000 | 0 | 15 Feb 2025 | Common Stock | 294 | Direct | F1, F2 | |
| transaction | NPO | Restricted Stock Units | Options Exercise | $0 | -217 | -33% | $0.000000 | 435 | 15 Feb 2025 | Common Stock | 217 | Direct | F1, F3 | |
| transaction | NPO | Restricted Stock Units | Options Exercise | $0 | -278 | -50% | $0.000000 | 280 | 16 Feb 2025 | Common Stock | 278 | Direct | F1, F4 |
| Id | Content |
|---|---|
| F1 | Each restricted stock unit represents the right to receive, at settlement, one share of common stock. |
| F2 | The restricted stock units will vest, subject to continued employment, in approximate equal thirds on 2/15/2023, 2/15/2024 and 2/15/2025. |
| F3 | The restricted stock units will vest, subject to continued employment, in approximate equal thirds on 2/15/2025, 2/15/2026 and 2/15/2027. |
| F4 | The restricted stock units will vest, subject to continued employment, in approximate equal thirds on 2/16/2024, 2/16/2025 and 2/16/2026. |